FDA Suspends Gene Therapy Studies at Penn

NPR's David Baron reports that the Food and Drug Administration has suspended all gene therapy studies at the University of Pennsylvania where an eighteen year old man died during an experiment last year. The study was put on hold because researchers violated regulations designed to protect patient safety.

Comments

 

Please keep your community civil. All comments must follow the NPR.org Community rules and terms of use, and will be moderated prior to posting. NPR reserves the right to use the comments we receive, in whole or in part, and to use the commenter's name and location, in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

Support comes from: